恶性肿瘤患者输注血小板临床效果分析

杨悦饶; 何明生; 和苗; 马娜; 陈玲; 向睿; 王燕

恶性肿瘤患者输注血小板临床效果分析

- 1 昆明医学院第三附属医院云南省肿瘤医院输血科(昆明, 650118);
- 2 昆明医学院第三附属医院云南省肿瘤医院血液科

详细信息

通讯作者: 何明生, E-mail:1145553479@qq.com

中图分类号: R331.1

收稿日期: 2011-12-16

Retrospective analysis of effectiveness of apheresis platelets transfusion in patients with malignant tumor

- 1. Department of Blood Transfusion, the 3rd Affiliated Hospital of Kunming Medical University, Kunming, 650118, China;
- 2. Department of Hematology, the 3rd Affiliated Hospital of Kunming Medical University

More Information

Corresponding author: HE Mingsheng, E-mail: 1145553479@qq.com

Received Date: 16 December 2011

摘要

摘要: 目的:探讨恶性肿瘤患者输注血小板的疗效及影响因素。方法:收集 505例恶性肿瘤患者939例次血小板输注前后,外周血小板计数,出血改善情况;输血次数;疾病类型及治疗方式。结果:单纯血小板降低者输注血小板后能提高外周血小板数,改善出血,有效率达84%,随输注次数增加有效率降低为79%,但脾大、感染、发热、凝血功能障碍等因素影响输注效果(P＜0.01)。疾病类型及治疗方式等也影响血小板输注效果,血小板减少病例中因化疗药物导致血小板减少占86%,血液病占13%,放疗导致血小板减少只占0.005%。结论:输注血小板能有效地治疗恶性肿瘤患者因疾病或化疗、放疗导致的血小板减少症,很多因素影响血小板输注。
- 恶性肿瘤 /
- 血小板 /
- 输注疗效
Abstract: Objective:To explore the efficacy and influencing factors of platelet transfusion in patients with malignant tumor.Method:The effects of platelet transfusion indications,before and after infusion of platelets,peripheral platelet count,number of transfusions,skin,mucous membrane,the improvement of organ hemorrhage were collected and analyzed.Result:After platelet infusion,the peripheral platelet count of those who simply platelet decreased could be improved and the bleeding were improved.While splenomegaly,infection,fever,coagulation dysfunction,infusion number,type of disease and treatment methods could affect platelet transfusion results.Conclusion:Platelet infusion could effectively treat cancer patients' thrombocytopenia induced by chemotherapy and radiotherapy,and many factors would affect platelet transfusion,therefore,platelet transfusion should be individualized.
- malignant tumor /
- platelet /
- transfusion efficacy

HTML全文

参考文献(15)

[1]	BLAJCHMAN M A.Substitutes and alternatives to platelet transfusions in thrombocytopenic patients[J].J Thromb Haemost,2003:1637-1641.
[2]	CHOUDHRY V P.Platelet therapy[J].Indian J Pediatr,2002,69:779-783.
[3]	TINMOUTH A T,FREEDMAN J.Prophylactic p latelet transfusions:which dose is the best dose?A review of the literat[J].Transfus Med Rev,2003,17:181-193.
[4]	BURGSTALER E A.Blood component collection by apheresis[J].J Clin Apher,2006,21:142-151.
[5]	王芳,贺冠强.基于循证医学的血小板输注指南[J].内科急危重症杂志,2008,2(14):109-112.
[6]	盛楚华,邱树彬,邱小华.血液病患者血小板输注效果评价及影响因素分析[J].中国全科医学,2006,9(16):1332-1334.
[7]	滕本秀,段前碧,段慧玲,等.输注机采血小板在血液病患者中的效果分析[J].重庆医学,2006,35(11):973-974.
[8]	HEAL J M. BLUMBERG N.Optimizing platelet transfusion therapy[J].Blood Rev,2004,18:149-165.
[9]	SLICHTER S J.Platelet transfusion therapy[J].Hematol Oncol Clin North Am,2007,21:697-729.
[10]	KAUFMAN R M.Platelets:testing,dosing and the storage le2sion-recent advances[J].Hematology,2006:492-496.
[11]	STRAUSS R G.Pretransfusion trigger platelet counts and dose for prophylactic platelet transfusions[J].Curr Opin Hematol,2005,12:499-502.
[12]	刘景汉,林武存.临床输血指南[M].北京:人民军医出版社,1998:15-17.
[13]	安全,陈方平,周淑娟,等.186例血液病患者血小板输注临床分析[J].临床血液学杂志,2007,3(20):169-170.
[14]	徐丽娟,于海龙,刘斌杰,等.血小板输注无效的临床分析[J].临床输血与检验,2008,1(10):59-60.
[15]	汪得清,张晓娟,关晓珍,等.972例血液病患者输注机采血小板后回顾性分析[J].中国输血杂志,2008,4(21):248-249.